Holger F Rabenau

InstitutionGoethe University Frankfurt am Main
AddressFrankfurt
Germany
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 14 Covid-19 publications, with a maximum of 3 publications in June 2020
    All Publications
    Bar chart showing 148 publications over 25 distinct years, with a maximum of 12 publications in 2002
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hoehl S, Kreutzer E, Schenk B, Westhaus S, Foppa I, Herrmann E, Ettrich I, Leondaraki M, Schaible A, Rudych O, Rabenau H, Berger A, Ciesek S. Longitudinal Testing for Respiratory and Gastrointestinal Shedding of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Day Care Centers in Hesse, Germany. Clin Infect Dis. 2021 11 02; 73(9):e3036-e3041. PMID: 33388748.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    2. Widera M, Wilhelm A, Hoehl S, Pallas C, Kohmer N, Wolf T, Rabenau HF, Corman VM, Drosten C, Vehreschild MJGT, Goetsch U, Gottschalk R, Ciesek S. Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro. J Infect Dis. 2021 10 13; 224(7):1109-1114. PMID: 34223909.
      Citations: 16     Fields:    Translation:Humans
    3. Plenzig S, Holz F, Bojkova D, Kettner M, Cinatl J, Verhoff MA, Birngruber CG, Ciesek S, Rabenau HF. Detection and infectivity of SARS-CoV-2 in exhumated corpses. Int J Legal Med. 2021 Nov; 135(6):2531-2536. PMID: 34302215.
      Citations: 2     Fields:    Translation:Humans
    4. Widera M, Westhaus S, Rabenau HF, Hoehl S, Bojkova D, Cinatl J, Ciesek S. Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings. Med Microbiol Immunol. 2021 Aug; 210(4):235-244. PMID: 34196781.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    5. Kohmer N, Rühl C, Ciesek S, Rabenau HF. Utility of Different Surrogate Enzyme-Linked Immunosorbent Assays (sELISAs) for Detection of SARS-CoV-2 Neutralizing Antibodies. J Clin Med. 2021 May 14; 10(10). PMID: 34069088.
      Citations: 8     
    6. Weiss R, Guchlerner L, Loth AG, Leinung M, Wicker S, Kempf VAJ, Berger A, Rabenau HF, Ciesek S, Stöver T, Diensthuber M. Typical symptoms of common otorhinolaryngological diseases may mask a SARS-CoV-2 infection. Eur Arch Otorhinolaryngol. 2021 Sep; 278(9):3551-3558. PMID: 33677653.
      Citations: 1     Fields:    Translation:Humans
    7. Kohmer N, Rabenau HF, Hoehl S, Kortenbusch M, Ciesek S, Berger A. Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs). J Virol Methods. 2021 05; 291:114102. PMID: 33607117.
      Citations: 3     Fields:    Translation:Humans
    8. Kohmer N, Toptan T, Pallas C, Karaca O, Pfeiffer A, Westhaus S, Widera M, Berger A, Hoehl S, Kammel M, Ciesek S, Rabenau HF. The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro. J Clin Med. 2021 Jan 17; 10(2). PMID: 33477365.
      Citations: 33     
    9. Neef V, Buxmann H, Rabenau HF, Zacharowski K, Raimann FJ. Characterization of neonates born to mothers with SARS-CoV-2 infection: Review and meta-analysis. Pediatr Neonatol. 2021 01; 62(1):11-20. PMID: 33334687.
      Citations: 3     Fields:    Translation:Humans
    10. Kohmer N, Westhaus S, Rühl C, Ciesek S, Rabenau HF. Clinical performance of different SARS-CoV-2 IgG antibody tests. J Med Virol. 2020 10; 92(10):2243-2247. PMID: 32510168.
      Citations: 56     Fields:    Translation:Humans
    11. Muenchhoff M, Mairhofer H, Nitschko H, Grzimek-Koschewa N, Hoffmann D, Berger A, Rabenau H, Widera M, Ackermann N, Konrad R, Zange S, Graf A, Krebs S, Blum H, Sing A, Liebl B, Wölfel R, Ciesek S, Drosten C, Protzer U, Boehm S, Keppler OT. Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020. Euro Surveill. 2020 06; 25(24). PMID: 32583765.
      Citations: 19     Fields:    Translation:HumansCellsPHPublic Health
    12. Kohmer N, Westhaus S, Rühl C, Ciesek S, Rabenau HF. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays. J Clin Virol. 2020 08; 129:104480. PMID: 32505777.
      Citations: 79     Fields:    Translation:HumansCellsPHPublic Health
    13. Corman VM, Rabenau HF, Adams O, Oberle D, Funk MB, Keller-Stanislawski B, Timm J, Drosten C, Ciesek S. SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission. Transfusion. 2020 06; 60(6):1119-1122. PMID: 32361996.
      Citations: 33     Fields:    Translation:HumansCellsPHPublic Health
    14. Hoehl S, Rabenau H, Berger A, Kortenbusch M, Cinatl J, Bojkova D, Behrens P, Böddinghaus B, Götsch U, Naujoks F, Neumann P, Schork J, Tiarks-Jungk P, Walczok A, Eickmann M, Vehreschild MJGT, Kann G, Wolf T, Gottschalk R, Ciesek S. Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China. N Engl J Med. 2020 03 26; 382(13):1278-1280. PMID: 32069388.
      Citations: 218     Fields:    Translation:HumansCellsPHPublic Health
    15. Rabenau HF, Kampf G, Cinatl J, Doerr HW. Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect. 2005 Oct; 61(2):107-11. PMID: 15923059.
      Citations: 101     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    16. Rabenau HF, Biesert L, Schmidt T, Bauer G, Cinatl J, Doerr HW. SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation. Biologicals. 2005 Jun; 33(2):95-9. PMID: 15939287.
      Citations: 16     Fields:    Translation:HumansCells
    17. Rabenau HF, Cinatl J, Morgenstern B, Bauer G, Preiser W, Doerr HW. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol. 2005 Jan; 194(1-2):1-6. PMID: 15118911.
      Citations: 202     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    18. Giroglou T, Cinatl J, Rabenau H, Drosten C, Schwalbe H, Doerr HW, von Laer D. Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein. J Virol. 2004 Sep; 78(17):9007-15. PMID: 15308697.
      Citations: 58     Fields:    Translation:HumansAnimalsCells
    19. Cinatl J, Hoever G, Morgenstern B, Preiser W, Vogel JU, Hofmann WK, Bauer G, Michaelis M, Rabenau HF, Doerr HW. Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus. Cell Mol Life Sci. 2004 Aug; 61(16):2100-12. PMID: 15316659.
      Citations: 32     Fields:    Translation:HumansCells
    20. Yamamoto N, Yang R, Yoshinaka Y, Amari S, Nakano T, Cinatl J, Rabenau H, Doerr HW, Hunsmann G, Otaka A, Tamamura H, Fujii N, Yamamoto N. HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. Biochem Biophys Res Commun. 2004 Jun 04; 318(3):719-25. PMID: 15144898.
      Citations: 127     Fields:    Translation:AnimalsCells
    21. Thiel V, Ivanov KA, Putics Á, Hertzig T, Schelle B, Bayer S, Weißbrich B, Snijder EJ, Rabenau H, Doerr HW, Gorbalenya AE, Ziebuhr J. Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol. 2003 Sep; 84(Pt 9):2305-2315. PMID: 12917450.
      Citations: 374     Fields:    Translation:Cells
    22. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Treatment of SARS with human interferons. Lancet. 2003 Jul 26; 362(9380):293-4. PMID: 12892961.
      Citations: 197     Fields:    Translation:HumansCells
    23. Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003 Jun 14; 361(9374):2045-6. PMID: 12814717.
      Citations: 342     Fields:    Translation:HumansAnimalsCells
    24. Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguière AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Müller S, Rickerts V, Stürmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003 May 15; 348(20):1967-76. PMID: 12690091.
      Citations: 1705     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    25. Rabenau H, Knoll B, Allwinn R, Doerr HW, Weber B. Improvement of the specificity of enzyme immunoassays for the detection of rotavirus and adenovirus in fecal specimens. Intervirology. 1998; 41(2-3):55-62. PMID: 9820838.
      Citations: 4     Fields:    Translation:HumansCells
    Rabenau's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (213)
    Explore
    _
    Co-Authors (103)
    Explore
    _
    Similar People (60)
    Explore
    _